Literature DB >> 26733177

MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer.

Min Zheng1, Zhihao Wu1, Anqi Wu2, Zhenyu Huang2, Na He2, Xiaohong Xie3.   

Abstract

Researches indicate that the dysregulation of microRNA (miRNA) is involved in tumorigenesis. Among such dysregulated miRNAs in cancer, miR-145 is reported to be downregulated in multiple cancers. In this study, we demonstrated the downregulation of miR-145 in triple-negative breast cancer (TNBC) tissues and TNBC cell lines by quantitative reverse-transcription polymerase chain reaction (RT-PCR) analysis. Furthermore, we found that the tumor necrosis factor-alpha (TNF-α)-induced apoptosis was expanded by the transfection of miR-145 in MDA-MB-231 which belongs to the TNBC cell lines. We then indicated that the mechanism by which miR-145 promotes the TNF-α-induced apoptosis is dependent on the formation of RIP1-FADD-caspase-8 complex. The cellular inhibitor of apoptosis (cIAP1), which is the inhibitor of apoptosis protein, was found to be a target of miR-145 in MDA-MB-231 cells. As a result of cIAP1 overexpression, the promotion of miR-145 on TNF-α-induced apoptosis was inhibited in MDA-MB-231 cells. Therefore, our results indicate that miR-145 acts as a tumor suppressor in TNBC, suggesting that the miR-145-cIAP1 axis might be a potential therapeutic target for TNBC.

Entities:  

Keywords:  RIP1-FADD-caspase-8; TNBC; TNF-α; cIAP1; miR-145

Mesh:

Substances:

Year:  2016        PMID: 26733177     DOI: 10.1007/s13277-015-4631-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

Review 3.  Exploring miRNA based approaches in cancer diagnostics and therapeutics.

Authors:  Shivangi Mishra; Tanuja Yadav; Vibha Rani
Journal:  Crit Rev Oncol Hematol       Date:  2015-10-08       Impact factor: 6.312

4.  RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.

Authors:  B A Abhari; S Cristofanon; R Kappler; D von Schweinitz; R Humphreys; S Fulda
Journal:  Oncogene       Date:  2012-08-13       Impact factor: 9.867

Review 5.  Emerging targeted therapies in triple-negative breast cancer.

Authors:  J Crown; J O'Shaughnessy; G Gullo
Journal:  Ann Oncol       Date:  2012-08       Impact factor: 32.976

Review 6.  MicroRNA and cancer.

Authors:  Martin D Jansson; Anders H Lund
Journal:  Mol Oncol       Date:  2012-10-09       Impact factor: 6.603

7.  miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells.

Authors:  Su'e Chang; Ling Gao; Yang Yang; Dongdong Tong; Bo Guo; Liying Liu; Zongfang Li; Tusheng Song; Chen Huang
Journal:  Oncotarget       Date:  2015-04-10

8.  A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis.

Authors:  Yi Ma; Shaojun Zhao; Shutao Shen; Shixiong Fang; Zulu Ye; Zhi Shi; An Hong
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

9.  miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.

Authors:  Kinya Okamoto; Kenichi Miyoshi; Yoshikazu Murawaki
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

10.  Structure-Activity Relationship of Synthetic 2-Phenylnaphthalenes with Hydroxyl Groups that Inhibit Proliferation and Induce Apoptosis of MCF-7 Cancer Cells.

Authors:  Chi-Fen Chang; Ci-Yi Ke; Yang-Chang Wu; Ta-Hsien Chuang
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

View more
  12 in total

1.  Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.

Authors:  Ramzi M Mohammad; Yiwei Li; Irfana Muqbil; Amro Aboukameel; William Senapedis; Erkan Baloglu; Yosef Landesman; Philip A Philip; Asfar S Azmi
Journal:  Small GTPases       Date:  2017-06-23

2.  MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3.

Authors:  Xiaowei Wu; Lin Li; Yi Li; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2016-07-01       Impact factor: 6.166

Review 3.  Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential.

Authors:  Dharambir Kashyap; Hardeep Singh Tuli; Vivek Kumar Garg; Neelam Goel; Anupam Bishayee
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

4.  TNF-α Triggers RIP1/FADD/Caspase-8-Mediated Apoptosis of Astrocytes and RIP3/MLKL-Mediated Necroptosis of Neurons Induced by Angiostrongylus cantonensis Infection.

Authors:  Hongli Zhou; Minyu Zhou; Yue Hu; Yanin Limpanon; Yubin Ma; Ping Huang; Paron Dekumyoy; Wanchai Maleewong; Zhiyue Lv
Journal:  Cell Mol Neurobiol       Date:  2021-03-08       Impact factor: 4.231

Review 5.  RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review).

Authors:  Yuping Liu; Ting Liu; Tiantian Lei; Dingding Zhang; Suya Du; Lea Girani; Dandan Qi; Chen Lin; Rongsheng Tong; Yi Wang
Journal:  Int J Mol Med       Date:  2019-06-14       Impact factor: 4.101

6.  JAG2/Notch2 inhibits intervertebral disc degeneration by modulating cell proliferation, apoptosis, and extracellular matrix.

Authors:  Jun Long; Xiaobo Wang; Xianfa Du; Hehai Pan; Jianru Wang; Zemin Li; Hui Liu; Xudong Li; Zhaomin Zheng
Journal:  Arthritis Res Ther       Date:  2019-10-16       Impact factor: 5.156

Review 7.  MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.

Authors:  Lei Ding; Huan Gu; Xianhui Xiong; Hongshun Ao; Jiaqi Cao; Wen Lin; Min Yu; Jie Lin; Qinghua Cui
Journal:  Cells       Date:  2019-11-22       Impact factor: 6.600

8.  Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.

Authors:  Marketa Koleckova; Jiri Ehrmann; Jan Bouchal; Maria Janikova; Aneta Brisudova; Josef Srovnal; Katerina Staffova; Marek Svoboda; Ondrej Slaby; Lenka Radova; Katherine Vomackova; Bohuslav Melichar; Lucia Veverkova; Zdenek Kolar
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 9.  MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review.

Authors:  Simona Ruxandra Volovat; Constantin Volovat; Irina Hordila; Dorin-Alexandru Hordila; Ciprian Camil Mirestean; Oana Tatiana Miron; Cristian Lungulescu; Dragos Viorel Scripcariu; Cati Raluca Stolniceanu; Assia Adrianova Konsoulova-Kirova; Cristina Grigorescu; Cipriana Stefanescu; Cristian Constantin Volovat; Iolanda Augustin
Journal:  Front Oncol       Date:  2020-11-20       Impact factor: 6.244

Review 10.  The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer.

Authors:  Getinet M Adinew; Equar Taka; Patricia Mendonca; Samia S Messeha; Karam F A Soliman
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.